Literature DB >> 23127678

Prescription drug overdoses: a review.

Leonard J Paulozzi1.   

Abstract

PROBLEM: Overdoses involving prescription drugs in the United States have reached epidemic proportions over the past 20 years.
METHODS: This review categorizes and summarizes literature on the topic dating from the first published reports through 2011 using a traditional epidemiologic model of host, agent, and environment.
RESULTS: Host factors include male sex, middle age, non-Hispanic white race, low income, and mental health problems. Agent risk factors include use of opioid analgesics and benzodiazepines, high prescribed dosage for opioid analgesics, multiple prescriptions, and multiple prescribers. Environmental factors include rural residence and high community prescribing rates. DISCUSSION: The epidemiology of prescription drug overdoses differs from the epidemiology of illicit drug overdoses. Incomplete understanding of prescription overdoses impedes prevention efforts.
SUMMARY: This epidemic demands additional attention from injury professionals. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127678     DOI: 10.1016/j.jsr.2012.08.009

Source DB:  PubMed          Journal:  J Safety Res        ISSN: 0022-4375


  86 in total

1.  Risk factors associated with benzodiazepine use among people who inject drugs in an urban Canadian setting.

Authors:  Devin Tucker; Kanna Hayashi; M-J Milloy; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood
Journal:  Addict Behav       Date:  2015-10-09       Impact factor: 3.913

2.  High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.

Authors:  David Frank; Pedro Mateu-Gelabert; Honoria Guarino; Alex Bennett; Travis Wendel; Lauren Jessell; Anastasia Teper
Journal:  Int J Drug Policy       Date:  2014-07-31

3.  Motivations for the nonmedical use of prescription drugs in a longitudinal national sample of young adults.

Authors:  Tess K Drazdowski; Lourah M Kelly; Wendy L Kliewer
Journal:  J Subst Abuse Treat       Date:  2020-04-29

4.  Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances.

Authors:  Denise B Kandel; Mei-Chen Hu; Pamela Griesler; Melanie Wall
Journal:  Drug Alcohol Depend       Date:  2017-07-04       Impact factor: 4.492

5.  Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population.

Authors:  Daniel T Hackman; Marion S Greene; Taya J Fernandes; Ashley M Brown; Eric R Wright; R Andrew Chambers
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

6.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.

Authors:  Rahi Abouk; Rosalie Liccardo Pacula; David Powell
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

7.  Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.

Authors:  Richard A Slivicki; Shahin A Saberi; Vishakh Iyer; V Kiran Vemuri; Alexandros Makriyannis; Andrea G Hohmann
Journal:  J Pharmacol Exp Ther       Date:  2018-10-01       Impact factor: 4.030

8.  The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use among an Incarcerated Population in Kentucky, 2008-2016.

Authors:  Amanda M Bunting; Grant Victor; Erika Pike; Michele Staton
Journal:  Crim Justice Policy Rev       Date:  2019-03-31

9.  Location of fatal prescription opioid-related deaths in 12 states, 2008-2010: Implications for prevention programs.

Authors:  Keith W Easterling; Karin A Mack; Christopher M Jones
Journal:  J Safety Res       Date:  2016-08-07

10.  Impact of Perioperative Epidural Placement on Postdischarge Opioid Use in Patients Undergoing Abdominal Surgery.

Authors:  Karim S Ladha; Elisabetta Patorno; Jun Liu; Brian T Bateman
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.